Related Experiment Video
Updated: Jul 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Dickkopf-1 activates cell death in MDA-MB435 melanoma cells
Andrei M Mikheev1, Svetlana A Mikheeva, Robert Rostomily
1Program in Cancer Biology, Divisions of Human Biology and Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA 98104-2092, USA.
Abstract:
Dickkopf-1 (DKK-1) is known inhibitor of the canonical Wnt pathway. Recent studies strongly suggested that activation of DKK-1 expression results in inhibition of cell tumorigenicity. Reduced levels of DKK-1 in melanomas were recently shown. However, it is not known if DKK-1 activation in melanoma cells will inhibit cell tumorigenicity. In the present study, we overexpressed DKK-1 in melanoma cell line MDA-MB435. We show that while DKK-1 did not affect cell growth in soft agar, weak but significant inhibition of tumorigenicity in nude mice in vivo was observed. Analysis of resulting tumors revealed activation of cell death. In tumors originating from cells transduced with DKK-1, tumor mass was permeated with areas of necrosis. In tumors, originated from control cells, areas of necrosis were limited to the central region, a common feature of large tumors growing in nude mice. TUNEL assay revealed that in tumors originating from cells transduced with DKK-1 apoptotic cells were detected along the border of necrotic and viable areas of the tumors indicating significant increase in apoptotic process. Thus, our results indicate that activation of DKK-1 in melanoma cells leads to activation of apoptosis in vivo and, thus, is incompatible with tumor growth in nude mice.
Insights
Activating Dickkopf-1 (DKK-1) in melanoma cells showed weak inhibition of tumor growth in mice. This suggests DKK-1 may promote apoptosis, making it incompatible with melanoma tumor progression.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Dickkopf-1 (DKK-1) is a known inhibitor of the canonical Wnt pathway.
- Recent studies suggest DKK-1 activation inhibits cell tumorigenicity.
- Reduced DKK-1 levels are observed in melanomas.
Purpose of the Study:
- To investigate if DKK-1 activation inhibits melanoma cell tumorigenicity.
- To determine the effect of DKK-1 overexpression on melanoma growth in vivo.
Main Methods:
- Overexpression of DKK-1 in the MDA-MB435 melanoma cell line.
- Assessment of cell growth in soft agar.
- Evaluation of tumorigenicity in nude mice.
- Analysis of tumor necrosis and apoptosis using TUNEL assay.
Main Results:
- DKK-1 overexpression did not affect cell growth in soft agar.
- A weak but significant inhibition of tumorigenicity in nude mice was observed.
- Tumors from DKK-1 overexpressing cells showed increased necrosis and apoptosis.
Conclusions:
- DKK-1 activation in melanoma cells leads to apoptosis in vivo.
- Increased apoptosis is incompatible with melanoma tumor growth in nude mice.
- DKK-1 may represent a potential therapeutic target for melanoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation
Inhibition of Cdk Activity

